88 related articles for article (PubMed ID: 35583077)
1. SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression.
Walhart TA; Vacca B; Hepperla AJ; Hamad SH; Petrongelli J; Wang Y; McKean EL; Moksa M; Cao Q; Yip S; Hirst M; Weissman BE
Am J Pathol; 2023 Apr; 193(4):456-473. PubMed ID: 36657718
[TBL] [Abstract][Full Text] [Related]
2. Loss of Integrase Interactor 1 (INI1) Expression in a Subset of Differentiated Thyroid Cancer.
Ho KC; Lee JJ; Lin CH; Leung CH; Cheng SP
Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32380731
[TBL] [Abstract][Full Text] [Related]
3. A Rare Case of Rhabdoid Pancreatic Carcinoma: Prolonged Disease-Free Survival Following Upfront Resection and Adjuvant Chemotherapy.
Land G; Van Haeringen B; Cooper C; Andelkovic V; O'Rourke T
Cureus; 2023 Dec; 15(12):e50145. PubMed ID: 38186431
[TBL] [Abstract][Full Text] [Related]
4. Primary extrarenal rhabdoid tumour of the liver: a case report and literature review.
Meyers Michel; Demetter Pieter; De Roo An-Katrien; Pezzullo Martina; Jungels Christiane; Brichard Bénédicte; De Magnee Catherine; De Krijger Ronald R; Verset Gontran
Acta Gastroenterol Belg; 2023; 86(4):555-562. PubMed ID: 38240550
[TBL] [Abstract][Full Text] [Related]
5. Retraction: SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma.
Biosci Rep; 2023 Nov; 43(11):. PubMed ID: 37921048
[No Abstract] [Full Text] [Related]
6. Osteosarcoma.
Beird HC; Bielack SS; Flanagan AM; Gill J; Heymann D; Janeway KA; Livingston JA; Roberts RD; Strauss SJ; Gorlick R
Nat Rev Dis Primers; 2022 Dec; 8(1):77. PubMed ID: 36481668
[TBL] [Abstract][Full Text] [Related]
7. Commentary on: SMARCB1 as a novel diagnostic and prognostic biomarker for osteosarcoma.
Sergi CM
Biosci Rep; 2022 Jun; 42(6):. PubMed ID: 35583077
[TBL] [Abstract][Full Text] [Related]
8. SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma.
Guo T; Wei R; Dean DC; Hornicek FJ; Duan Z
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34984436
[TBL] [Abstract][Full Text] [Related]
9. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
10. SMARCB1/INI1-deficient tumors of adulthood.
Parker NA; Al-Obaidi A; Deutsch JM
F1000Res; 2020; 9():662. PubMed ID: 33796273
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic roles of SMARCB1/INI1 and its deficient tumors.
Kohashi K; Oda Y
Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176
[TBL] [Abstract][Full Text] [Related]
12. Pathology and diagnosis of SMARCB1-deficient tumors.
Margol AS; Judkins AR
Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
